J. Gossmann

发表

H. Geiger, K. Schulte, T. Lenz, 2002, Clinical laboratory.

ABCB1 genotype of the donor but not of the recipient is a major risk factor for cyclosporine-related nephrotoxicity after renal transplantation.

H. Ackermann, M. Eichelbaum, M. Schwab, 2005, Journal of the American Society of Nephrology : JASN.

Long‐Term Consequences of Live Kidney Donation Follow‐Up in 93% of Living Kidney Donors in a Single Transplant Center

Jochen Jordan, E. Scheuermann, H. Geiger, 2005, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Effect of sirolimus on malignancy and survival after kidney transplantation: systematic review and meta-analysis of individual patient data

G. Knoll, M. Guba, R. Ducharme, 2014, BMJ : British Medical Journal.

Vascular endothelial growth factor and its soluble receptor, Flt‐1, are not correlated to erythropoietin in diabetics with normal or reduced renal function

S. Gauer, T. Haak, R. Bergner, 2005, Nephrology.

Switch to a Sirolimus‐Based Immunosuppression in Long‐Term Renal Transplant Recipients: Reduced Rate of (Pre‐)Malignancies and Nonmelanoma Skin Cancer in a Prospective, Randomized, Assessor‐Blinded, Controlled Clinical Trial

R. Kaufmann, E. Scheuermann, H. Geiger, 2010, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Angiotensin II infusion increases plasma erythropoietin levels via an angiotensin II type 1 receptor-dependent pathway.

E. Scheuermann, H. Geiger, S. Harder, 2001, Kidney international.

Mechanism of angiotensin converting enzyme inhibitor-related anemia in renal transplant recipients.

E. Scheuermann, W. Schoeppe, P. Thürmann, 1996, Kidney international.

Evaluation of type 1 diabetics for simultaneous pancreas-kidney transplantation with regard to cardiovascular risk.

W. Bechstein, I. Hauser, H. Geiger, 2006, Transplantation proceedings.

Immunosuppressive therapy regimen and platelet activation in renal transplant patients

E. Scheuermann, S. Harder, U. Klinkhardt, 2002, Clinical pharmacology and therapeutics.

Living kidney donors' long-term psychological status and health behavior after nephrectomy - a retrospective study.

Jochen Jordan, E. Scheuermann, H. Kachel, 2004, Journal of nephrology.

Vascular Endothelial Growth Factor in Diabetic Nephropathy

H. Gröne, T. Haak, T. Lenz, 2003, Kidney and Blood Pressure Research.

Anti‐inflammatory effects of clopidogrel intake in renal transplant patients: Effects on platelet‐leukocyte interactions, platelet CD40 ligand expression, and proinflammatory biomarkers

E. Scheuermann, S. Harder, J. Graff, 2005, Clinical pharmacology and therapeutics.

Effect of angiotensin II infusion with and without angiotensin II type 1 receptor blockade on nitric oxide metabolism and endothelin in human beings: A placebo‐controlled study in healthy volunteers

E. Scheuermann, T. Haak, H. Geiger, 2000, Clinical pharmacology and therapeutics.

Exhaustive exercise-induced tissue hypoxia does not change endothelin and big endothelin plasma levels in normal volunteers.

H. Geiger, G. Oremek, T. Lenz, 1998, American journal of hypertension.

Abrogation of nephrotic proteinuria by rituximab treatment in a renal transplant patient with relapsed focal segmental glomerulosclerosis

I. Hauser, E. Scheuermann, H. Geiger, 2007, Transplant international : official journal of the European Society for Organ Transplantation.

Pharmacokinetic Analysis of Mycophenolate Mofetil and Enteric-Coated Mycophenolate Sodium in Calcineurin Inhibitor–Free Renal Transplant Recipients

M. Oellerich, E. Scheuermann, G. Brandhorst, 2016, Therapeutic drug monitoring.

ANEMIA IN RENAL TRANSPLANT RECIPIENTS CAUSED BY CONCOMITANT THERAPY WITH AZATHIOPRINE AND ANGIOTENSIN‐CONVERTING ENZYME INHIBITORS

E. Scheuermann, W. Schoeppe, J. Gossmann, 1993, Transplantation.

Chirurgie des Kindesalters

J. Gossmann, R. Drachter, 1930 .

Reactivation of hepatitis B two years after rituximab therapy in a renal transplant patient with recurrent focal segmental glomerulosclerosis: a note of caution

I. Hauser, E. Scheuermann, H. Geiger, 2009, Clinical transplantation.

Residual kidney function after donor nephrectomy

F. Grünwald, C. Menzel, J. Gossmann, 2005, Nuklearmedizin.

Postoperative voiding dysfunction in older male renal transplant recipients.

W. Bentas, R. Blaheta, I. Tsaur, 2009, Transplantation proceedings.

Renal transplantation in the elderly: surgical complications and outcome with special emphasis on the Eurotransplant Senior Programme.

D. Jonas, W. Bentas, I. Hauser, 2008, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Antituberculous drugs in kidney transplant recipients treated with cyclosporine.

E. Scheuermann, W. Schoeppe, B. Peschke, 1993, Transplantation.

Development of urological cancers in renal transplant recipients: 30‐year experience at the Frankfurt Transplant Center

D. Jonas, R. Blaheta, N. Obermüller, 2010, Cancer science.

Curable hypertensive renal failure due to iliac artery stenosis in a kidney transplant recipient.

D. Liermann, T. Lenz, J. Gossmann, 1997, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

A randomized prospective double-blind placebo-controlled study of gallopamil, calcium antagonist of the verapamil type, in stable cyclosporine-treated renal transplant recipients.

E. Scheuermann, H. Geiger, A. Dietz, 2002, Transplantation proceedings.

Proteinuria and sirolimus after renal transplantation: a retrospective analysis from a large German multicenter database

N. Heyne, K. Budde, F. Eitner, 2014, Clinical transplantation.

Determinants of Successful Use of Sirolimus in Renal Transplant Patients.

N. Heyne, K. Budde, F. Eitner, 2020, Transplantation proceedings.

Cyclophosphamide-Induced Bladder Cancer

J. Gossmann, 1997, Annals of Internal Medicine.

Rejection quantity in kidney transplant recipients is associated with increasing intracellular interleukin-2 in CD8+ T-cells.

E. Herrmann, S. Zeuzem, E. Scheuermann, 2014, Transplant Immunology.

Multiple adenomas and hepatocellular carcinoma in a renal transplant patient with glycogen storage disease type 1a (von Gierke disease).

C. Dietrich, E. Scheuermann, H. Geiger, 2001, Transplantation.

Disseminated BK type polyomavirus infection in an AIDS patient associated with central nervous system disease.

J. Löhler, D. Petersen, K. Dörries, 1993, The American journal of pathology.

Mechanism of recovery from acute virus infection. IX. Clearance of lymphocytic choriomeningitis (LCM) virus from the feet of mice undergoing LCM virus-specific delayed-type hypersensitivity reaction.

D. Moskophidis, Lubin Fang, J. Gossmann, 1989, The Journal of general virology.